The quarter beat on revenue but missed on earnings. Revenue was $1.15 million versus a published consensus near $0.93 million, while diluted EPS was negative $0.24 versus expectations near negative $0.15 to negative $0.16. The revenue beat is modest in absolute terms and does not change the underlying picture: sales declined from $1.20 million a year earlier, while operating expenses rose 16% to $21.4 million. (Statements of Comprehensive Loss)
| Figure | Q2 2026 | Q2 2025 | External expectation / comparison |
|---|---|---|---|
| Revenue | $1.150 million | $1.202 million | Consensus: ~$0.93 million |
| Operating loss | $(20.249) million | $(17.240) million | — |
| Net loss | $(33.755) million | $(63.195) million | — |
| Diluted EPS | $(0.24) | $(0.48) | Consensus: roughly $(0.15)–$(0.16) |
| Operating cash flow, six months | $(28.021) million | $(25.703) million | — |
| Cash, equivalents and short-term investments | $228.837 million | — | — |
| Long-term debt | — | $273.589 million at Dec. 31, 2025 | — |
The core business remains far from commercial scale. Revenue fell 4% year over year, and the operating loss widened to $20.2 million from $17.2 million as research and development and selling, general and administrative costs increased. The improvement in net loss was largely accounting-driven: the quarter included a $21.4 million debt-extinguishment gain, partly offset by $28.4 million of derivative-liability losses. (Statements of Comprehensive Loss)
The balance sheet is materially stronger, but much of that improvement was already known. All $190 million of convertible debt was converted into approximately 15.2 million shares, and the public-warrant exercise generated approximately $169.5 million of gross proceeds. That left no long-term debt and about $298 million of stated available liquidity after collecting warrant proceeds on July 1. (Financial Highlights; Balance Sheet) These are meaningful reductions in financing risk, but the conversion and warrant actions had been announced before this earnings release, limiting their incremental surprise value.
Cash runway improved, not cash economics. Six-month operating cash burn was $28.0 million, slightly worse than $25.7 million a year earlier, while equity-based compensation increased to $11.0 million from $8.0 million. (Cash Flow statement) The larger cash balance buys time to pursue the FCC process and build partnerships, but the filing provides no new revenue guidance, commercialization milestone, or evidence that spending is translating into accelerating sales.
The net read is modestly negative versus expectations. The revenue beat and removal of debt overhang are genuine positives, but the larger-than-expected per-share loss, declining revenue base, widening operating loss, and continued cash burn matter more for the quarter’s operating read. The new Tiami partnership and previously announced Safran collaboration add validation, not reported revenue or firm commercial commitments. (Operational Highlights)
Read the original 8-K on SEC EDGAR ↗